Open Access Research article

Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial

Dona L Fleishaker*, Juan A Garcia Meijide, Andriy Petrov, Michael David Kohen, Xin Wang, Sujatha Menon, Thomas C Stock, Charles A Mebus, James M Goodrich, Howard B Mayer and Bernhardt G Zeiher

Arthritis Research & Therapy 2012, 14:R11  doi:10.1186/ar3685

See related editorial by Takeuchi and Kameda,

Article Metrics

Total accesses

BioMed Central citations

Article metric FAQ


  • Last 30 days: 96 accesses
  • Last 365 days: 1154 accesses
  • All time: 3964 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information

Cited by